AngioDynamics, Inc.
ANGO
Rank in Stocks
#11864
AngioDynamics, Inc. specializes in the development, manufacturing, and... AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The company's portfolio includes advanced ablation systems like NanoKnife, designed for the precise surgical removal of soft tissues, and Solero microwave and radiofrequency systems, effective in ablating solid cancerous or benign growths. Additionally, they provide BioSentry tract sealant systems, IsoLoc Endorectal Balloons, Alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. Their endovascular therapies segment encompasses solutions for thrombus management, atherectomy procedures, core peripheral products, and the treatment of venous insufficiency. Furthermore, AngioDynamics is a key supplier of vascular access devices, such as peripherally inserted central catheters (PICCs), midline catheters, implantable ports, and dialysis catheters, along with associated accessories. These are primarily employed for short-duration systemic drug delivery, including chemotherapy and antibiotics, marketed under a robust portfolio of brand names such as BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax. The company distributes its offerings directly to a specialized clientele, including interventional radiologists, cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses, while also leveraging established distributor networks. Founded in 1988, AngioDynamics maintains its corporate headquarters in Latham, New York.
Share Price
$12.42
Last synced: 2026-11-11
Market Cap
$521.91M
Change (1 day)
2.90%
Change (1 year)
0.98%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade AngioDynamics, Inc. (ANGO)
Category
Healthcare
Earnings for AngioDynamics, Inc. (ANGO)
Earnings in Aug 2026 TTM: $-32.76M
According to AngioDynamics, Inc.'s latest financial reports, its current earnings (TTM) are $-32.76M. In 2025 the company earned $-34.03M, an increase over its 2024 earnings of $-191.64M. The earnings shown on this page are earnings before interest and taxes, or EBIT.
Earnings history for AngioDynamics, Inc. from 2001 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $-32.76M | -3.74% |
| 2025 | $-34.03M | -82.24% |
| 2024 | $-191.64M | 252.04% |
| 2023 | $-54.44M | 81.77% |
| 2022 | $-29.95M | -16.93% |
| 2021 | $-36.05M | -78.56% |
| 2020 | $-168.14M | 1,043.62% |
| 2019 | $-14.70M | -14.84% |
| 2018 | $-17.26M | 20.76% |
| 2017 | $-14.30M | 339.44% |
| 2016 | $-3.25M | -59.99% |
| 2015 | $-8.13M | -256.79% |
| 2014 | $5.19M | -426.78% |
| 2013 | $-1.59M | -70.73% |
| 2012 | $-5.42M | -150.68% |
| 2011 | $10.70M | -45.47% |
| 2010 | $19.62M | 29.48% |
| 2009 | $15.15M | -12.56% |
| 2008 | $17.33M | -341.61% |
| 2007 | $-7.17M | -164.48% |
| 2006 | $11.12M | 46.00% |
| 2005 | $7.62M | 73.89% |
| 2004 | $4.38M | 94.28% |
| 2003 | $2.26M | 43.63% |
| 2002 | $1.57M | -234.19% |
| 2001 | $-1.17M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $3.62B | -11,147.68% |
US
|
|
| $3.86B | -11,892.31% |
FR
|
|
| $1.98B | -6,147.38% |
US
|
|
| $2.32B | -7,174.93% |
JP
|
|
| $1.12B | -3,512.91% |
US
|
Questions about AngioDynamics, Inc.'s net income
What is AngioDynamics, Inc.'s net income?
AngioDynamics, Inc.'s net income over the last twelve months is $-32.76M, as of Aug 2026.
What was AngioDynamics, Inc.'s net income in 2025?
In 2025, AngioDynamics, Inc.'s net income was $-34.03M, compared with $-191.64M in 2024.
How has AngioDynamics, Inc.'s net income changed since 2020?
From 2020 to 2025, AngioDynamics, Inc.'s net income was highest in 2022 ($-29.95M) and lowest in 2024 ($-191.64M).
How does AngioDynamics, Inc.'s net income compare with similar companies?
AngioDynamics, Inc.'s net income ($-32.76M) is lower than that of all 5 similar companies listed above. The highest among them is EssilorLuxottica S.A., with $3.86B.